Ganoderma Lucidum (Reishi) – Phytosterols – Curcumin – Andrographis Paniculata – Houttuynia Cordata Thunb – Boesenbergia rotunda (Boesenbergia pandurata) – Antioxidants and free radicals – Prebiotics and Probiotics

Ganoderma Lucidum (Reishi)

• Chen RY ; Yu DQ. Studies on the triterpenoid constituents of the des from spores Ganoderma lucidum karst. Yao Hsueh Hsueh Pao, 26:267-73, 1991.
• Chen WC ; Hau DM ; Wang CC ; Lin IH ; Il lit SUIV.. Effects of ganoderma lucidum and krestin on subset T-cell in spleen of gamma-irradiated mice.
• Am J Chin Med, 23:289-98, 1995
• Chen TW ; Wong YK ; Il lit SUIV.. In vitro cytotoxicity of Ganoderma lucidum on cancer cells oral. Chung Hua I Hsueh Tsa Chih (Taïpeh), 48:54-8, 1991 Jul.
• Chen WC ; Hau DM ; Il lit SUIV.. Effects of Ganoderma lucidum and krestin on cellular immunocompetence in gamma-ray-irradiated mice. Am J Chin Med, 23:71-80, 1995.
• Gau JP ; Lin CK ; Il lit SUIV. ; Wang M. The lack of antiplatelet effect of crude extracts from ganoderma lucidum on Hiv-positive hemophiliacs.
• Am J Chin Med, 18:175-9, 1990.
• Il y ai Y ; Li R ; Chen Q ; Lin Z ; Xia D ; Ma L. Chemical studies on immunologically active polysaccharides of Ganoderma lucidum(Leyss. ex Fr.) Karst. Chung Kuo Chung Yao Tsa Chih, 17:226-8, 256,.1992 Apr.
• Hsu HY ; Ils lient SL ; Lin CC. Radioprotective effect of Ganoderma lucidum (ex Leyss.. Fr.) Karst after X-ray irradiation in mice. Am J Chin Med, 18:61-9, 1990.
• Kawagishi H ; Mitsunaga S ; Yamawaki M ; Allé M ; Shimada A ; Kinoshita T ;
• Murata T ; Usui T ; Kimura A ; Chiba S A lectin from mycelia of the fungus Ganoderma lucidum. Phytochemistry, 44:7-10, 1997 Jan.
• Koyama K ; Imaizumi T ; Akiba M ; Kinoshita K ; Takahashi K ; Suzuki A ; Yano S ; Horie S ; Watanabe K ; Naoi Et Antinociceptive components of Ganoderma lucidum. Plante Med, 63:224-7, 1997 Jun.
• Kim RS ; Kim HW ; Kim BK. Suppressive effects of Ganoderma lucidum on proliferation of peripheral blood mononuclear cells. Mol Cells, 7:52-7, 1997 Feb 28.
• Il lit SY ; Rhee HM. Cardiovasculaire effects of mycelium extract of Ganoderma lucidum:inhibition of sympathetic outflow as a mechanism of its hypotensive action. Chem Pharm Bull (Tokyo), 38:1359-64, 1990 May.
• Lin CN ; Prenez WP ; Won SJ. Novel cytotoxic principles of Formosan Ganoderma lucidum. J Nat Prod, 54:998-1002, 1991 Jul-Aug.
• Lin JM ; Lin CC ; Chiu HF ; Yang JJ ; Il lit SG. Evaluation of the anti-inflammatory and liver-protective effects of anoectochilus formosanus, ganoderma lucidum and gynostemma pentaphyllum in rats. Am J Chin Med, 21:59-69, 1993.
• Lin JM ; Lin CC ; Chen MF ; Ujiie T ; Takada à scavenger and Radical antihepatotoxic activity of Ganoderma formosanum, Ganoderma lucidum and Ganoderma neo-japonicum. J Ethnopharmacol, 47:33-41, 1995 Jun 23.
• Lieu CW ; Il lit SUIV. ; Wang SY. The effect of Ganoderma lucidum on induction of differentiation in leukemic U937 cells. Bête antie-cancer, 12:1211-5, 1992 Jul-Aug.
• Parcs EX ; Ko G ; Kim J ; Sohn DH. Antifibrotic effects of polysaccharide extracted from à Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction. Biol Pharm Bull, 20:417-20, 1997 Apr.
• Tao J ; Feng KY Expérimental and clinical studies on inhibitory effect of ganoderma lucidum on platelet aggregation. J Tongji Med Univ, 10:240-3, 1990.
• Wang SY ; Hsu ML ; Hsu HC ; Tzeng CH ; Il lit SUIV. ; Shiao MS ; Ho CK.
• The anti-tumor effect of Ganoderma lucidum is mediated by cytokinesreleased from activated macrophages and T lymphocytes. Int J Cancer, 70:699-705, 1997 Mers 17.
• Yun TK ; Kim SH ; Il lit YS Trial of new medium-term model using benzo(a)pyrene induced lung tumor in newborn mice. Bête antie-cancer, 15:839-45, 1995 May-Jun.
• Zhang LX ; Mong H ; Zhou XB. Effect of Japanese Ganoderma Lucidum on production of interleukin-2 from murine splenocytes. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih, 13:613-5, 582,.1993 Oct

(Source: www.hipernatural.com)

Phytosterols

1. Jenkins DJ, Kendall CW, Marchie A, et al. The Garden of Eden–plant based diets, the genetic drive to conserve cholesterol and its implications for heart disease in the 21st century. Comp Biochem Physiol A Mol Integr Physiol. 2003;136(1):141-151. (PubMed)

2. Kendall CW, Jenkins DJ. A dietary portfolio: maximal reduction of low-density lipoprotein cholesterol with diet. Curr Atheroscler Rep. 2004;6(6):492-498. (PubMed)

3. Ostlund RE, Jr. Phytosterols in human nutrition. Annu Rev Nutr. 2002;22:533-549. (PubMed)

4. Sudhop T, Lutjohann D, von Bergmann K. Sterol transporters: targets of natural sterols and new lipid lowering drugs. Pharmacol Ther. 2005;105(3):333-341. (PubMed)

5. de Jong A, Plat J, Mensink RP. Metabolic effects of plant sterols and stanols (Review). J Nutr Biochem. 2003;14(7):362-369.
(PubMed)

6. Plat J, Mensink RP. Plant stanol and sterol esters in the control of blood cholesterol levels: mechanism and safety aspects. Am J Cardiol. 2005;96(1 Suppl):15-22. (PubMed)

7. von Bergmann K, Sudhop T, Lutjohann D. Cholesterol and Plant Sterol Absorption: Recent Insights. Am J Cardiol. 2005;96(1S):10-14.
(PubMed)

8. Ostlund RE, Jr., McGill JB, Zeng CM, et al. Gastrointestinal absorption and plasma kinetics of soy Delta(5)-phytosterols and phytostanols in humans. Am J Physiol Endocrinol Metab. 2002;282(4):E911-916. (PubMed)

9. Sudhop T, Sahin Y, Lindenthal B, et al. Comparison of the hepatic clearances of campesterol, sitosterol, and cholesterol in healthy subjects suggests that efflux transporters controlling intestinal sterol absorption also regulate biliary secretion. Gut. 2002;51(6):860-863.
(PubMed)

10. Berger A, Jones PJ, Abumweis SS. Plant sterols: factors affecting their efficacy and safety as functional food ingredients. Lipids Health Dis. 2004;3(1):5. (PubMed)

11. Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc. 2003;78(8):965-978.
(PubMed)

12. Nissinen M, Gylling H, Vuoristo M, Miettinen TA. Micellar distribution of cholesterol and phytosterols after duodenal plant stanol ester infusion. Am J Physiol Gastrointest Liver Physiol. 2002;282(6):G1009-1015. (PubMed)

13. Jones PJ, Raeini-Sarjaz M, Ntanios FY, Vanstone CA, Feng JY, Parsons WE. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res. 2000;41(5):697-705.
(PubMed)

14. Normen L, Dutta P, Lia A, Andersson H. Soy sterol esters and beta-sitostanol ester as inhibitors of cholesterol absorption in human small bowel. Am J Clin Nutr. 2000;71(4):908-913. (PubMed)

15. Richelle M, Enslen M, Hager C, et al. Both free and esterified plant sterols reduce cholesterol absorption and the bioavailability of beta-carotene and alpha-tocopherol in normocholesterolemic humans. Am J Clin Nutr. 2004;80(1):171-177. (PubMed)

16. Plat J, Mensink RP. Effects of plant stanol esters on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression in mononuclear blood cells of healthy men and women. FASEB J. 2002;16(2):258-260. (PubMed)

17. Mouritsen OG, Zuckermann MJ. What’s so special about cholesterol? Lipids. 2004;39(11):1101-1113. (PubMed)

18. Halling KK, Slotte JP. Membrane properties of plant sterols in phospholipid bilayers as determined by differential scanning calorimetry, resonance energy transfer and detergent-induced solubilization. Biochim Biophys Acta. 2004;1664(2):161-171. (PubMed)

19. Awad AB, Chen YC, Fink CS, Hennessey T. beta-Sitosterol inhibits HT-29 human colon cancer cell growth and alters membrane lipids. Anticancer Res. 1996;16(5A):2797-2804. (PubMed)

20. Leikin AI, Brenner RR. Fatty acid desaturase activities are modulated by phytosterol incorporation in microsomes. Biochim Biophys Acta. 1989;1005(2):187-191. (PubMed)

21. Ratnayake WM, L’Abbe MR, Mueller R, et al. Vegetable oils high in phytosterols make erythrocytes less deformable and shorten the life span of stroke-prone spontaneously hypertensive rats. J Nutr. 2000;130(5):1166-1178. (PubMed)

22. Ratnayake WM, Plouffe L, L’Abbe MR, Trick K, Mueller R, Hayward S. Comparative health effects of margarines fortified with plant sterols and stanols on a rat model for hemorrhagic stroke. Lipids. 2003;38(12):1237-1247. (PubMed)

23. Jones PJ, Raeini-Sarjaz M, Jenkins DJ, et al. Effects of a diet high in plant sterols, vegetable proteins, and viscous fibers (dietary portfolio) on circulating sterol levels and red cell fragility in hypercholesterolemic subjects. Lipids. 2005;40(2):169-174. (PubMed)

24. Awad AB, Hartati MS, Fink CS. Phytosterol feeding induces alteration in testosterone metabolism in rat tissues. J Nutr Biochem. 1998;9(12):712-717.

25. Cabeza M, Bratoeff E, Heuze I, Ramirez E, Sanchez M, Flores E. Effect of beta-sitosterol as inhibitor of 5 alpha-reductase in hamster prostate. Proc West Pharmacol Soc. 2003;46:153-155. (PubMed)

26. Hendriks HF, Brink EJ, Meijer GW, Princen HM, Ntanios FY. Safety of long-term consumption of plant sterol esters-enriched spread. Eur J Clin Nutr. 2003;57(5):681-692. (PubMed)

27. von Holtz RL, Fink CS, Awad AB. beta-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells. Nutr Cancer. 1998;32(1):8-12. (PubMed)

28. Awad AB, Roy R, Fink CS. Beta-sitosterol, a plant sterol, induces apoptosis and activates key caspases in MDA-MB-231 human breast cancer cells. Oncol Rep. 2003;10(2):497-500. (PubMed)

29. Choi YH, Kong KR, Kim YA, et al. Induction of Bax and activation of caspases during beta-sitosterol-mediated apoptosis in human colon cancer cells. Int J Oncol. 2003;23(6):1657-1662. (PubMed)

30. Awad AB, Toczek J, Fink CS. Phytosterols decrease prostaglandin release in cultured P388D1/MAB macrophages. Prostaglandins Leukot Essent Fatty Acids. 2004;70(6):511-520. (PubMed)

31. Navarro A, De las Heras B, Villar A. Anti-inflammatory and immunomodulating properties of a sterol fraction from Sideritis foetens Clem. Biol Pharm Bull. 2001;24(5):470-473. (PubMed)

32. St-Onge MP, Jones PJ. Phytosterols and human lipid metabolism: efficacy, safety, and novel foods. Lipids. 2003;38(4):367-375.
(PubMed)

33. Law M. Plant sterol and stanol margarines and health. BMJ. 2000;320(7238):861-864. (PubMed)

34. Chen JT, Wesley R, Shamburek RD, Pucino F, Csako G. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy. 2005;25(2):171-183. (PubMed)

35. Hendriks HF, Weststrate JA, van Vliet T, Meijer GW. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr. 1999;53(4):319-327. (PubMed)

36. Miettinen TA, Vanhanen H. Dietary sitostanol related to absorption, synthesis and serum level of cholesterol in different apolipoprotein E phenotypes. Atherosclerosis. 1994;105(2):217-226. (PubMed)

37. Pelletier X, Belbraouet S, Mirabel D, et al. A diet moderately enriched in phytosterols lowers plasma cholesterol concentrations in normocholesterolemic humans. Ann Nutr Metab. 1995;39(5):291-295. (PubMed)

38. Sierksma A, Weststrate JA, Meijer GW. Spreads enriched with plant sterols, either esterified 4,4-dimethylsterols or free 4-desmethylsterols, and plasma total- and LDL-cholesterol concentrations. Br J Nutr. 1999;82(4):273-282. (PubMed)

39. Volpe R, Niittynen L, Korpela R, et al. Effects of yoghurt enriched with plant sterols on serum lipids in patients with moderate hypercholesterolaemia. Br J Nutr. 2001;86(2):233-239. (PubMed)

40. Hallikainen MA, Sarkkinen ES, Gylling H, Erkkila AT, Uusitupa MI. Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur J Clin Nutr. 2000;54(9):715-725. (PubMed)

41. Vanstone CA, Raeini-Sarjaz M, Parsons WE, Jones PJ. Unesterified plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons. Am J Clin Nutr. 2002;76(6):1272-1278.
(PubMed)

42. Weststrate JA, Meijer GW. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr. 1998;52(5):334-343. (PubMed)

43. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med. 1995;333(20):1308-1312.
(PubMed)

44. Miettinen TA, Gylling H. Plant stanol and sterol esters in prevention of cardiovascular diseases. Ann Med. 2004;36(2):126-134.
(PubMed)

45. O’Neill FH, Brynes A, Mandeno R, et al. Comparison of the effects of dietary plant sterol and stanol esters on lipid metabolism. Nutr Metab Cardiovasc Dis. 2004;14(3):133-142. (PubMed)

46. National Cholesterol Education Program. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Heart Lung and Blood Institute, National Institutes of Health. 2002. Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3_rpt.htm.

47. Grundy SM. Stanol Esters as a Component of Maximal Dietary Therapy in the National Cholesterol Education Program Adult Treatment Panel III Report. Am J Cardiol. 2005;96(1 Suppl):47-50. (PubMed)

48. Jones PJ, Ntanios FY, Raeini-Sarjaz M, Vanstone CA. Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men. Am J Clin Nutr. 1999;69(6):1144-1150.
(PubMed)

49. Jenkins DJ, Kendall CW, Marchie A, et al. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr. 2005;81(2):380-387.
(PubMed)

50. Food and Drug Administration. Health claims: plant sterol/stanol esters and risk of coronary heart disease (CHD). U. S. Government Printing Office. 2002. Available at: http://www.cfsan.fda.gov/~lrd/cf101-83.html.

51. Ostlund RE, Jr. Phytosterols and cholesterol metabolism. Curr Opin Lipidol. 2004;15(1):37-41. (PubMed)

52. Ostlund RE, Jr., Racette SB, Stenson WF. Effects of trace components of dietary fat on cholesterol metabolism: phytosterols, oxysterols, and squalene. Nutr Rev. 2002;60(11):349-359. (PubMed)

53. Andersson SW, Skinner J, Ellegard L, et al. Intake of dietary plant sterols is inversely related to serum cholesterol concentration in men and women in the EPIC Norfolk population: a cross-sectional study. Eur J Clin Nutr. 2004;58(10):1378-1385. (PubMed)

54.Ostlund RE, Jr., Racette SB, Okeke A, Stenson WF. Phytosterols that are naturally present in commercial corn oil significantly reduce cholesterol absorption in humans. Am J Clin Nutr. 2002;75(6):1000-1004.
(PubMed)

55. Ostlund RE, Jr., Racette SB, Stenson WF. Inhibition of cholesterol absorption by phytosterol-replete wheat germ compared with phytosterol-depleted wheat germ. Am J Clin Nutr. 2003;77(6):1385-1389.
(PubMed)

56. Ju YH, Clausen LM, Allred KF, Almada AL, Helferich WG. beta-Sitosterol, beta-Sitosterol Glucoside, and a Mixture of beta-Sitosterol and beta-Sitosterol Glucoside Modulate the Growth of Estrogen-Responsive Breast Cancer Cells In Vitro and in Ovariectomized Athymic Mice. J Nutr. 2004;134(5):1145-1151. (PubMed)

57. Awad AB, Fink CS, Williams H, Kim U. In vitro and in vivo (SCID mice) effects of phytosterols on the growth and dissemination of human prostate cancer PC-3 cells. Eur J Cancer Prev. 2001;10(6):507-513.
(PubMed)

58. Awad AB, Downie A, Fink CS, Kim U. Dietary phytosterol inhibits the growth and metastasis of MDA-MB-231 human breast cancer cells grown in SCID mice. Anticancer Res. 2000;20(2A):821-824. (PubMed)

59. De Stefani E, Boffetta P, Ronco AL, et al. Plant sterols and risk of stomach cancer: a case-control study in Uruguay. Nutr Cancer. 2000;37(2):140-144. (PubMed)

60. Mendilaharsu M, De Stefani E, Deneo-Pellegrini H, Carzoglio J, Ronco A. Phytosterols and risk of lung cancer: a case-control study in Uruguay. Lung Cancer. 1998;21(1):37-45. (PubMed)

61. Ronco A, De Stefani E, Boffetta P, Deneo-Pellegrini H, Mendilaharsu M, Leborgne F. Vegetables, fruits, and related nutrients and risk of breast cancer: a case-control study in Uruguay. Nutr Cancer. 1999;35(2):111-119. (PubMed)

62. McCann SE, Freudenheim JL, Marshall JR, Brasure JR, Swanson MK, Graham S. Diet in the epidemiology of endometrial cancer in western New York (United States). Cancer Causes Control. 2000;11(10):965-974.
(PubMed)

63. McCann SE, Freudenheim JL, Marshall JR, Graham S. Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr. 2003;133(6):1937-1942.
(PubMed)

64. Strom SS, Yamamura Y, Duphorne CM, et al. Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr Cancer. 1999;33(1):20-25. (PubMed)

65. Berges RR, Windeler J, Trampisch HJ, Senge T. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group. Lancet. 1995;345(8964):1529-1532. (PubMed)

66. Berges RR, Kassen A, Senge T. Treatment of symptomatic benign prostatic hyperplasia with beta-sitosterol: an 18-month follow-up. BJU Int. 2000;85(7):842-846. (PubMed)

67. Klippel KF, Hiltl DM, Schipp B. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group. Br J Urol. 1997;80(3):427-432. (PubMed)

68. Wilt TJ, MacDonald R, Ishani A. beta-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review. BJU Int. 1999;83(9):976-983. (PubMed)

69. Dreikorn K. The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia. World J Urol. 2002;19(6):426-435. (PubMed)

70. Nair PP, Turjman N, Kessie G, et al. Diet, nutrition intake, and metabolism in populations at high and low risk for colon cancer. Dietary cholesterol, beta-sitosterol, and stigmasterol. Am J Clin Nutr. 1984;40(4 Suppl):927-930. (PubMed)

71. Mensink RP, Ebbing S, Lindhout M, Plat J, van Heugten MM. Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble antioxidant concentrations. Atherosclerosis. 2002;160(1):205-213. (PubMed)

72. Noakes M, Clifton PM, Doornbos AME, Trautwein EA. Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects. Eur J Clin Nutr. 2005;44(4):214-222. (PubMed)

73. Thomsen AB, Hansen HB, Christiansen C, Green H, Berger A. Effect of free plant sterols in low-fat milk on serum lipid profile in hypercholesterolemic subjects. Eur J Clin Nutr. 2004;58(6):860-870.
(PubMed)

74. Devaraj S, Jialal I, Vega-Lopez S. Plant sterol-fortified orange juice effectively lowers cholesterol levels in mildly hypercholesterolemic healthy individuals. Arterioscler Thromb Vasc Biol. 2004;24(3):e25-28.
(PubMed)

75. Matvienko OA, Lewis DS, Swanson M, et al. A single daily dose of soybean phytosterols in ground beef decreases serum total cholesterol and LDL cholesterol in young, mildly hypercholesterolemic men. Am J Clin Nutr. 2002;76(1):57-64. (PubMed)

76. Plat J, van Onselen EN, van Heugten MM, Mensink RP. Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. Eur J Clin Nutr. 2000;54(9):671-677.
(PubMed)

77. Food and Drug Administration. GRAS Notice No. GRN 000112. 2003. Available at: http://www.cfsan.fda.gov/~rdb/opa-g112.html.

78. Scientific Committee on Food. Opinion on Applications for Approval of a Variety of Plant Sterol-Enriched Foods. 2003. Available at: http://europa.eu.int/comm/food/fs/sc/scf/out174_en.pdf. Safety evaluation of phytosterol esters. Part 5. Faecal short-chain fatty acid and microflora content, faecal bacterial enzyme activity and serum female sex hormones in healthy normolipidaemic volunteers consuming a controlled diet either with or without a phytosterol ester-enriched margarine. Food Chem Toxicol. 1999;37(12):1127-1138. (PubMed)

80. Berge KE. Sitosterolemia: a gateway to new knowledge about cholesterol metabolism. Ann Med. 2003;35(7):502-511. (PubMed)

81. Stalenhoef AF, Hectors M, Demacker PN. Effect of plant sterol-enriched margarine on plasma lipids and sterols in subjects heterozygous for phytosterolaemia. J Intern Med. 2001;249(2):163-166.
(PubMed)

82. Kwiterovich PO, Jr., Chen SC, Virgil DG, Schweitzer A, Arnold DR, Kratz LE. Response of obligate heterozygotes for phytosterolemia to a low-fat diet and to a plant sterol ester dietary challenge. J Lipid Res. 2003;44(6):1143-1155. (PubMed)

83. Normen L, Holmes D, Frohlich J. Plant sterols and their role in combined use with statins for lipid lowering. Curr Opin Investig Drugs. 2005;6(3):307-316. (PubMed)

84. Thompson GR. Additive effects of plant sterol and stanol esters to statin therapy. Am J Cardiol. 2005;96(1 Suppl):37-39.
(PubMed)

85. Blair SN, Capuzzi DM, Gottlieb SO, Nguyen T, Morgan JM, Cater NB. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am J Cardiol. 2000;86(1):46-52.
(PubMed)

86. Neil HA, Meijer GW, Roe LS. Randomised controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterol-enriched fat spread. Atherosclerosis. 2001;156(2):329-337. (PubMed)

87. Simons LA. Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia. Am J Cardiol. 2002;90(7):737-740. (PubMed)

88. Nguyen TT, Dale LC. Plant stanol esters and vitamin K. Mayo Clin Proc. 1999;74(6):642-643. (PubMed)

89. Raeini-Sarjaz M, Ntanios FY, Vanstone CA, Jones PJ. No changes in serum fat-soluble vitamin and carotenoid concentrations with the intake of plant sterol/stanol esters in the context of a controlled diet. Metabolism. 2002;51(5):652-656. (PubMed)

90. Plat J, Mensink RP. Vegetable oil based versus wood based stanol ester mixtures: effects on serum lipids and hemostatic factors in non-hypercholesterolemic subjects. Atherosclerosis. 2000;148(1):101-112.
(PubMed)

91. Plat J, Mensink RP. Effects of diets enriched with two different plant stanol ester mixtures on plasma ubiquinol-10 and fat-soluble antioxidant concentrations. Metabolism. 2001;50(5):520-529.
(PubMed)

92. Ntanios FY, Duchateau GS. A healthy diet rich in carotenoids is effective in maintaining normal blood carotenoid levels during the daily use of plant sterol-enriched spreads. Int J Vitam Nutr Res. 2002;72(1):32-39. (PubMed)

93. Noakes M, Clifton P, Ntanios F, Shrapnel W, Record I, McInerney J. An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. Am J Clin Nutr. 2002;75(1):79-86. (PubMed)

94. Normen L, Bryngelsson S, Johnsson M, et al. The phytosterol content of some cereal foods commonly consumed in Sweden and in the Netherlands. J Food Compos Anal. 2002;15(6):693-704.

95. Normen L, Johnsson M, Andersson H, van Gameren Y, Dutta P. Plant sterols in vegetables and fruits commonly consumed in Sweden. Eur J Nutr. 1999;38(2):84-89. (PubMed)

96. Phillips KM, Ruggio DM, Toivo JI, Swank MA, Simpkins AH. Free and esterified sterol composition of edible oils and fats. J Food Compos Anal. 2002;15(2):123-142.

97. U.S. Department of Agriculture, Agricultural Research Service. USDA Nutrient Database for Standard Reference, Release 17. 2004.

(Source: Linus Pauling Institute)

Curcumin

1. Aggarwal BB, Kumar A, Aggarwal MS, Shishodia S. Curcumin derived from turmeric (Curcuma longa): a spice for all seasons. In: Preuss H, ed. Phytopharmaceuticals in Cancer Chemoprevention. Boca Raton: CRC Press; 2005:349-387.

2. Sharma RA, Gescher AJ, Steward WP. Curcumin: The story so far. Eur J Cancer. 2005;41(13):1955-1968. (PubMed)

3. Ireson CR, Jones DJ, Orr S, et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev. 2002;11(1):105-111. (PubMed)

4. Ireson C, Orr S, Jones DJ, et al. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 2001;61(3):1058-1064. (PubMed)

5. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21(4B):2895-2900. (PubMed)

6. Sharma RA, Euden SA, Platton SL, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004;10(20):6847-6854. (PubMed)

7. Garcea G, Berry DP, Jones DJ, et al. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev. 2005;14(1):120-125. (PubMed)

8. Garcea G, Jones DJ, Singh R, et al. Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer. 2004;90(5):1011-1015. (PubMed)

9. Sreejayan, Rao MN. Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol. 1997;49(1):105-107. (PubMed)

10. Sreejayan N, Rao MN. Free radical scavenging activity of curcuminoids. Arzneimittelforschung. 1996;46(2):169-171. (PubMed)

11. Steele VE, Hawk ET, Viner JL, Lubet RA. Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer. Mutat Res. 2003;523-524:137-144. (PubMed)

12. Hong J, Bose M, Ju J, et al. Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis. 2004;25(9):1671-1679. (PubMed)

13. Plummer SM, Holloway KA, Manson MM, et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene. 1999;18(44):6013-6020. (PubMed)

14. Brouet I, Ohshima H. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun. 1995;206(2):533-540.
(PubMed)

15. Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Thomas P, Dannenberg AJ. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. Am J Physiol Gastrointest Liver Physiol. 2003;284(2):G321-327. (PubMed)

16. Dickinson DA, Levonen AL, Moellering DR, et al. Human glutamate cysteine ligase gene regulation through the electrophile response element. Free Radic Biol Med. 2004;37(8):1152-1159. (PubMed)

17. Dickinson DA, Iles KE, Zhang H, Blank V, Forman HJ. Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression. Faseb J. 2003;17(3):473-475. (PubMed)

18. Lampe JW, Peterson S. Brassica, biotransformation and cancer risk: genetic polymorphisms alter the preventive effects of cruciferous vegetables. J Nutr. 2002;132(10):2991-2994. (PubMed)

19. Baird WM, Hooven LA, Mahadevan B. Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ Mol Mutagen. 2005;45(2-3):106-114. (PubMed)

20. Ciolino HP, Daschner PJ, Wang TT, Yeh GC. Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem Pharmacol. 1998;56(2):197-206.
(PubMed)

21. Rinaldi AL, Morse MA, Fields HW, et al. Curcumin activates the aryl hydrocarbon receptor yet significantly inhibits (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol bioactivation in oral squamous cell carcinoma cells and oral mucosa. Cancer Res. 2002;62(19):5451-5456. (PubMed)

22. Singh SV, Hu X, Srivastava SK, et al. Mechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcumin. Carcinogenesis. 1998;19(8):1357-1360. (PubMed)

23. Thapliyal R, Maru GB. Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo. Food Chem Toxicol. 2001;39(6):541-547.
(PubMed)

24. Iqbal M, Sharma SD, Okazaki Y, Fujisawa M, Okada S. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacol Toxicol. 2003;92(1):33-38.
(PubMed)

25. Susan M, Rao MN. Induction of glutathione S-transferase activity by curcumin in mice. Arzneimittelforschung. 1992;42(7):962-964.
(PubMed)

26. Stewart ZA, Westfall MD, Pietenpol JA. Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol Sci. 2003;24(3):139-145.
(PubMed)

27. Duvoix A, Blasius R, Delhalle S, et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 2005;223(2):181-190.
(PubMed)

28. Moos PJ, Edes K, Mullally JE, Fitzpatrick FA. Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis. 2004;25(9):1611-1617. (PubMed)

29. Tsvetkov P, Asher G, Reiss V, Shaul Y, Sachs L, Lotem J. Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci U S A. 2005;102(15):5535-5540. (PubMed)

30. Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res. 2002;62(13):3868-3875. (PubMed)

31. Banerji A, Chakrabarti J, Mitra A, Chatterjee A. Effect of curcumin on gelatinase A (MMP-2) activity in B16F10 melanoma cells. Cancer Lett. 2004;211(2):235-242. (PubMed)

32. Ohashi Y, Tsuchiya Y, Koizumi K, Sakurai H, Saiki I. Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model. Oncology. 2003;65(3):250-258. (PubMed)

33. Menon LG, Kuttan R, Kuttan G. Anti-metastatic activity of curcumin and catechin. Cancer Lett. 1999;141(1-2):159-165.
(PubMed)

34. Thaloor D, Singh AK, Sidhu GS, Prasad PV, Kleinman HK, Maheshwari RK. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ. 1998;9(4):305-312.
(PubMed)

35. Arbiser JL, Klauber N, Rohan R, et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med. 1998;4(6):376-383. (PubMed)

36. Krishnaswamy K, Goud VK, Sesikeran B, Mukundan MA, Krishna TP. Retardation of experimental tumorigenesis and reduction in DNA adducts by turmeric and curcumin. Nutr Cancer. 1998;30(2):163-166.
(PubMed)

37. Li N, Chen X, Liao J, et al. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis. 2002;23(8):1307-1313. (PubMed)

38. Ikezaki S, Nishikawa A, Furukawa F, et al. Chemopreventive effects of curcumin on glandular stomach carcinogenesis induced by N-methyl-N’-nitro-N-nitrosoguanidine and sodium chloride in rats. Anticancer Res. 2001;21(5):3407-3411. (PubMed)

39. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 1994;54(22):5841-5847. (PubMed)

40. Chuang SE, Kuo ML, Hsu CH, et al. Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis. 2000;21(2):331-335. (PubMed)

41. Pereira MA, Grubbs CJ, Barnes LH, et al. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis. 1996;17(6):1305-1311. (PubMed)

42. Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 1995;55(2):259-266. (PubMed)

43. Kawamori T, Lubet R, Steele VE, et al. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res. 1999;59(3):597-601.
(PubMed)

44. Mahmoud NN, Carothers AM, Grunberger D, et al. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis. 2000;21(5):921-927. (PubMed)

45. Perkins S, Verschoyle RD, Hill K, et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev. 2002;11(6):535-540.
(PubMed)

46. Singletary K, MacDonald C, Iovinelli M, Fisher C, Wallig M. Effect of the beta-diketones diferuloylmethane (curcumin) and dibenzoylmethane on rat mammary DNA adducts and tumors induced by 7,12-dimethylbenz[a]anthracene. Carcinogenesis. 1998;19(6):1039-1043.
(PubMed)

47. Huang MT, Lou YR, Xie JG, et al. Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. Carcinogenesis. 1998;19(9):1697-1700. (PubMed)

48. National Institutes of Health. Clinical Trials.gov. 2005. Available at: http://clinicaltrials.gov/.

49. Gandy S. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest. 2005;115(5):1121-1129.
(PubMed)

50. Cole GM, Morihara T, Lim GP, Yang F, Begum A, Frautschy SA. NSAID and Antioxidant Prevention of Alzheimer’s Disease: Lessons from In Vitro and Animal Models. Ann N Y Acad Sci. 2004;1035:68-84.
(PubMed)

51. Yang F, Lim GP, Begum AN, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005;280(7):5892-5901. (PubMed)

52. Frautschy SA, Hu W, Kim P, et al. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging. 2001;22(6):993-1005. (PubMed)

53. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci. 2001;21(21):8370-8377.
(PubMed)

54. Karunagaran D, Rashmi R, Kumar TR. Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets. 2005;5(2):117-129. (PubMed)

55. National Institutes of Health. An Introduction to Clinical Trials. 2005. Available at: http://clinicaltrials.gov/ct/info/whatis.

56. Deodhar SD, Sethi R, Srimal RC. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res. 1980;71:632-634. (PubMed)

57. Satoskar RR, Shah SJ, Shenoy SG. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther Toxicol. 1986;24(12):651-654.
(PubMed)

58. Lal B, Kapoor AK, Agrawal PK, Asthana OP, Srimal RC. Role of curcumin in idiopathic inflammatory orbital pseudotumours. Phytother Res. 2000;14(6):443-447. (PubMed)

59. Lal B, Kapoor AK, Asthana OP, et al. Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res. 1999;13(4):318-322. (PubMed)

60. Mall M, Kunzelmann K. Correction of the CF defect by curcumin: hypes and disappointments. Bioessays. 2005;27(1):9-13. (PubMed)

61.Egan ME, Pearson M, Weiner SA, et al. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science. 2004;304(5670):600-602. (PubMed)

62. Song Y, Sonawane ND, Salinas D, et al. Evidence against the rescue of defective DeltaF508-CFTR cellular processing by curcumin in cell culture and mouse models. J Biol Chem. 2004;279(39):40629-40633.
(PubMed)

63. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation to Fund Clinical Trial of Potential Curcumin Therapy. 2004. Available at: http://www.cff.org/research/cf_research_in_the_news/index.cfm?ID=2635&blnShowBack=False&idContentType=1213.

64. Cystic Fibrosis Foundation. Curcumin: Information for Patients and Families. 2004. Available at: http://www.cff.org/images/customcontent/CurcuminQAFinal.pdf.

65. Joe B, Vijaykumar M, Lokesh BR. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr. 2004;44(2):97-111. (PubMed)

66. Lechtenberg M, Quandt B, Nahrstedt A. Quantitative determination of curcuminoids in Curcuma rhizomes and rapid differentiation of Curcuma domestica Val. and Curcuma xanthorrhiza Roxb. by capillary electrophoresis. Phytochem Anal. 2004;15(3):152-158. (PubMed)

67. Heath DD, Khwaja F, Rock CL. Curcumin content of turmeric and curry powders. FASEB J. 2004;18(4):A125.

68. U.S. Food and Drug Administration. Food Additive Status List. 2005. Available at: http://www.cfsan.fda.gov/~dms/opa-appa.html.

69. Rasyid A, Lelo A. The effect of curcumin and placebo on human gall-bladder function: an ultrasound study. Aliment Pharmacol Ther. 1999;13(2):245-249. (PubMed)

70. Rasyid A, Rahman AR, Jaalam K, Lelo A. Effect of different curcumin dosages on human gall bladder. Asia Pac J Clin Nutr. 2002;11(4):314-318. (PubMed)

71. Shah BH, Nawaz Z, Pertani SA, et al. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochem Pharmacol. 1999;58(7):1167-1172.
(PubMed)

72. Srivastava KC, Bordia A, Verma SK. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukot Essent Fatty Acids. 1995;52(4):223-227. (PubMed)

73. Bano G, Raina RK, Zutshi U, Bedi KL, Johri RK, Sharma SC. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol. 1991;41(6):615-617. (PubMed)

74. Velpandian T, Jasuja R, Bhardwaj RK, Jaiswal J, Gupta SK. Piperine in food: interference in the pharmacokinetics of phenytoin. Eur J Drug Metab Pharmacokinet. 2001;26(4):241-247. (PubMed)

(Source: Linus Pauling Institute)

Andrographis Paniculata

Ana Ac, and Avadhoot Y. 1991. Hepatotective effect of Andrographis paniculata against carbontetrachloride-induced liver damage. Arch Pharm Res 14(1): 93-95.

Atsawasuwan P, Sirirat M, Amomchat C, Yudhasarasitihi S, et al. 1998. Subgingival administration of Andrographis paniculata gel and metronidazole gel as an adjunct in the treatment of adult periodontitis: clinical and microbiological effect effects. Mahidol J 5(2): 97-101.

Batkhun J. Hattori K, Takano F, et al. Suppression of NO production in activate macrophages in vito and ex vivo by neoandrographolide isolated from Andrographis paniculata. Biol Pharm Bull. 2002; 25(9): 1169-74.

Beijing Medical College, Physiology Department: Experimental observation on the termination of pregnancy by the Andrographis herb (Andrographis paniculata N.). Acta Physiologica Sinica. 1978; 30(10: 75-80.

Burgos RA, caballero EE, Sanche NS, et al. Testicular toxicity assessment of Andrographis paniculata dried extract in rats. J. Ethnopharmacol. 1997; 58: 219-224.

Caceres, D.D. et al. Prevemtion of common cold with Andrographis paniculata dried extract. A pilot doble-blind study. Phytomedicine 1997; 4: 101-104.

Caceres, D.D. et al. Use of visual analogue scale measurement (VAS) to assess the effectiveness of standardized Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. A randomized doble blind-placebo study. Phytomedicine 1999; 64: 217-223.

Choudhury BR, and Podder MK. 1984. Andrographolide and kalmegh(Andrographis paniculata) extract: in vivo and in vito effect on hepatic lipid peroxidation. Methods Find Exp Chin Pharmacol 6(9): 481-485.

Gupta S, Choudhry MA, Yadava JNS, et al. Antidiarrhoeal activity of diterpenes of andrographis piniculata(Kal-Megh) against Escherichia coli enterotoxin in in vivo models. Int. J. Crude Drug Res. 1990; 28(4): 273-283.

Hancke J, Burgos R, Caceres D, et al. A doule-blind study with a new monodrug Kan Jung: Decrease of symptoms and improvement in the recovery from common cold. Phytother. Res. 9: 559-562, 1995.

Handa SS, and Sharma A. 1990. Hepatoprotective activity of andrographolide from Andrographis paniculata against carbontetrachloride. Ind J Med Res 92” 276-283.

Handa SS, and Sharma A. 1990. Hepatoprotective activity of andrographolide against galactosamine & paracetamo; intoxication in rats. Ind J Med Res 92” 284-292.

Kamdem RF, Sang S, and Ho CT. 2002. Mechanism of superoxide scavenging activity of neoandrographolide a natural product from Andrographis paniculata Nees. J Agric Food Chem 50(16): 4662-4665.

Kapil A, Koul IB, Banerjee SK, and Gupta BD. 1993. antihepatotoxic effects of major diterpenoid constituents of Andrographis paniculata. Biochem Pharmacol 46(6): 182-185.

Leelarasamee A, Trakulsomboon S, Sittissomwong N. Undertectable antibacterial activity of Andrographis paniculata (Burm.) Wall. Ex Ness. J Med Assoc Thai 1990; 73(6)” 299-304.

Muangman V, Viseshsindh V, Ratana-Olam K, and Buadilok S. 1995. The usage of Andrographis paniculata following extracorporeal shock wave lithotripsy (ESWL). J. Med. Assoc. Thai. 78๖๗ซ 310-313.

Panossian A., Kochkian A, Gabrielain E, et al. Effect of Andrographis paniculata extract on progesterone in blood plasma of pregma,t rats. Phytomedicine. 1999; 3(3): 157-162.

Puri A et al. Immunostimulant agents from Andrographis paniculata. J. Nat. Pot.1993, 56: 995-999.

Rassameemasmaung S, Sirirat M, Komwatchara T, Rojanapanthu P, et al. 1998. Subgingingival administration of Andrographis paniculata gel as an adjunct in the treatment of adult periodontitis. Mahidol J 5(1): 9-15.

Shukla B, Visen PK, patnaik GK, and Dhawan BN. 1992. Choleretic effect of andrographolide in rats and guinea pigs. Planta Med 58(2): 146-149.

Singh RP, Banerjee A, and Rao AR. 2001. Modulatory influence of Andrographis paniculata on mouse hepatic and extrahephatic carcinogen metabolizing enzymes and antioxidant status. Phytother Res 15; 382-390.

Sittisomwongse N, et al. 1989. Acute and sub-chronic toxicity studies of Andrographis paniculata Nees. Th. J. Pharm. Sci. 14(2): 109-118.

Suttajit M, Immark K, Sukonpradit R, and Suttajit S. 1998. Antioxidative activityin medicinal herbs for HIV-infected patients. Proceeding of the 9th Annual Technical Meeting of the Department of Medical Sciences. P. 53.

Suttajit M, Immark K, Sukonpradit R, and Suttajit S. 1998. Antioxidative activityin medicinal herbs for HIV-infected patients. Proceeding of the 9th Annual Technical Meeting of the Department of Medical Sciences. P. 53.

Thamlikitkul, V. et al., Effect of Andrographis paniculata Nees for pharyngotonsiilitis in adults. J. Med. Assoc. Thai. 1991 ; 74(10): 433-442.

The Pharmacopoeia Commission of the Ministry of Public Health of PRC Herba Andrographitis. In: Pharmacopoeia of the people’s Republic of China (English Edition). Guoshi, T.U. ed. Lie Yung & Young Creation, Hong Kong 1988; 61-62.

Trivedi N, and Rawal UM. 1998. Effect of aqueous extract of Andrographis paniculata on severe liver tumor. Ind J Pharmacol 30: 318-322.

Trivedi N, and Rawal UM. 2000. Hepatoprotective and toxicological evaluation of Andrographis paniculata on severe liver damage. Ind J Pharmacol 32: 288-293.

Trivedi N, and Rawal UM. 2001. Hepatoprotective and antioxidant property of Andrographis paniculata(Nees) in BHC induced liver damagein mice. Ind J Exp Biol 39(1): 41-46.

Udomusksorn W. 1993. Effect of andrographolide and Andrographis paniculata on ethanol hepatotoxicity in rats. MS Thesis, Chulalongkorn University, Bangkok. 155 pages.

Vedavathy S, rao KN. Antipyretic activity of six indigenous medicinal plants of Tirumala Hills, Andhra Pradesh, India. J Ethnopharmacol. 1991; 33: 193-6

Visen PK, shukla B, patnaik GK, and Dhawan BN. 1993. Andrographolide protects rat hepatocytes against paracetamol-induced damage. J Ethnopharmacol 40(2): 131-136.

World Health Organization. Herba Andrographidis. In: WHO monographs of selected medicineal plants. Vol. 2. 2002. p. 12-24.

Zhang XF, and Tan BK. 2000. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats. Acta Pharmacol Sin 21(12): 1157-1164.

Zhang XF, and Tan BK. 2000. Antihyperglycaemic and anti-oxidant properties of Andrographis paniculata in normal and diabetic rats. Lin Exp Pharmacol Physiol 27(5-6): 358-363.

(Source: Database on Important Medicinal and Aromatic Plants, International Centre for Science and High Technology)

1. Hancke J, Burgos R, Caceres D, et al. A double-blind study with a new monodrug Kan Jang: decrease of symptoms and improvement in the recovery from common colds. Phytother Res . 1995;9:559-562.

2. Puri A, Saxena R, Saxena RP, et al. Immunostimulant agents from Andrographis paniculata. J Nat Prod. 1993;56:995-999.

3. Zhao HY, Fang WY. Antithrombotic effects of Andrographis paniculata nees in preventing myocardial infarction. Chin Med J (Engl). 1991,104:770-775.

4. Zhang CY, Tan BK. Mechanisms of cardiovascular activity of Andrographis paniculata in the anaesthetized rat. J Ethnopharmacol. 1997;56:97-101.

5. Wang DW, Zhao HY. Prevention of atherosclerotic arterial stenosis and restenosis after angioplasty with Andrographis paniculata nees and fish oil. Chin Med J (Engl). 1994;107:464-470.

6. Visen PKS, Shukla B, Patnaik GK, et al. Andrographolide protects rat hepatocytes against paracetamol-induced damage. J Ethnopharmacol. 1993;40:131-136.

7. Kapil A, Koul IB, Banerjee SK, et al. Antihepatotoxic effects of major diterpenoid constituents of Andrographis paniculata.Biochem Pharmacol. 1993;46:182-185.

8. Handa SS, Sharma A. Hepatoprotective activity of andrographolide from Andrographis paniculata against carbontetrachloride. Indian J Med Res. 1990;92:276-283.

9. Shukla B, Visen PKS, Patnaik GK, et al. Choleretic effect of andrographolide in rats and guinea pigs. Planta Med. 1992;58:146-149.

10. Leelarasamee A, Trakulsomboon S, Sittisomwong N. Undetectable anti-bacterial activity of Andrographis paniculata (Burma) wall. ex ness. J Med Assoc Thai. 1990;73:299-304.

11. Caceres DD, Hancke JL, Burgos RA, et al. Use of visual analogue scale measurements (VAS) to assess the effectiveness of standardized Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. A randomized double blind-placebo study. Phytomedicine. 1999;6:217-223.

12. Melchior J, Palm S, Wikman G. Controlled clinical study of standardized Andrographis paniculata extract in common cold – a pilot trial. Phytomedicine. 1996/1997;34:315-318.

13. Hancke J, Burgos R, Caceres D, et al. A double-blind study with a new monodrug Kan Jang: decrease of symptoms and improvement in the recovery from common colds. Phytother Res . 1995;9:559-562.

14. Caceres DD, Hancke JL, Burgos RA, et al. Use of visual analogue scale measurements (VAS) to assess the effectiveness of standardized Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. A randomized double blind-placebo study. Phytomedicine . 1999;6:217-223.

15. Melchior J, Spasov AA, Ostrovskij OV, et al. Double-blind, placebo-controlled pilot and phase III study of activity of standardized Andrographis paniculata Herba Nees extract fixed combination (Kan jang) in the treatment of uncomplicated upper-respiratory tract infection. Phytomedicine . 2000;7:341-350.

16. Thamlikitkul V, Dechatiwongse T, Theerapong S, et al. Efficacy of Andrographis paniculata (Nees) for pharyngotonsillitis in adults. J Med Assoc Thai .1991;74:437-442.

17. Caceres DD, Hancke JL, Burgos RA, et al. Prevention of common colds with Andrographis paniculata dried extract: a pilot double blind trial. Phytomedicine 1997;4:101-104.

18. Hancke J, Burgos R, Caceres D, et al. A double-blind study with a new monodrug Kan Jang: decrease of symptoms and improvement in the recovery from common colds. Phytother Res . 1995;9:559-562.

19. Akbarsha MA, Manivannan B, Shahul Hamid K, et al. Antifertility effect of Andrographis paniculata (Nees) in male albino rat. Indian J Exp Biol . 1990;28:421-426.

20. Burgos RA, Caballero EE, Sanchez NS, et al. Testicular toxicity assessment of Andrographis paniculata dried extract in rats. J Ethnopharmacol . 1997;58:219-224.

21. Zoha MS, Hussain AHM, Choudhury SAR. Antifertility effect of Andrographis paniculata in mice. Bangladesh Med Res Counc Bull . 1989;15:34-37.

22. Gabrielian ES, Shukarian AK, Goukasova GI, et al. A double blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis. Phytomedicine . 2002;9:589-597.

23. Burgos RA, Aguila MJ, Santiesteban ET. Andrographis paniculata (Nees) induces relaxation of uterus by blocking voltage operated calcium channels and inhibits Ca(+2) influx. Phytother Res . 2001;15:235-239.

24. Panossian A, Hambartsumyan M, Panosyan L, et al. Plasma nitric oxide level in familial Mediterranean fever and its modulations by Immuno-Guard. Nitric Oxide . 2003 Sep;9(2):103-10.

25. Amaryan G, Astvatsatryan V, Gabrielyan E, et al. Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard – a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail, and Glycyrrhiza glabra L . extracts in patients with familial Mediterranean fever. Phytomedicine . 2003;10:271-85.

26. Coon JT, Ernst E. Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy. Planta Med . 2004;70:293-8.

27. Spasov AA, Ostrovskij OV, Chernikov MV, et al. Comparative controlled study of Andrographis paniculata fixed combination, Kan Jang(R) and an echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in children. Phytother Res . 2004;18:47-53.

28. Kulichenko LL, Kireyeva LV, Malyshkina EN, et al. A randomized, controlled study of Kan Jang versus amantadine in the treatment of influenza in Volgograd. J Herb Pharmcother . 2003;3:77-92.

29. Mkrtchyan A, Panosyan V, Panossian A et al. A phase I clinical study of Andrographis paniculata fixed combination Kan Jang versus ginseng and valerian on the semen quality of healthy male subjects. Phytomedicine . 2005;12:403-9

(Source: Caremark Health Resources)

Houttuynia Cordata Thunb

1) Farnsworth N. R., Akerele O., Bingel A. S., Soejarto D. D., Guo Z., Bull. World Health Org., 63, 965—981 (1985).

2) Ji B., Zhao K., Chinese Med. Pharmaceut. J., 2, 14—16 (2003).

3) Sun J., Yang X. Z., Wang Y., Zhao J. X., China New Med. J., 1, 19—21 (2004).

4) Zhou J. N., China Tropical Med., 3, 500—502 (2003).

5) Hayashi K., Kamiya M., Hayashi T., Planta Med., 61, 237—241 (1995).

6) World Health Organization, General Guidelines for Methodologies on Research and Evaluation of Traditional Medicines, 2000.

7) World Health Organization, Guidelines for the Assessment of Herbal Medicines, 1991.

The State Drug Adminiatration of China, Technical Requirememts for Studing Fingerprint of Traditional Chinese Medicine Injection (Draft), 2000.

9) Liang Y. Z., Xie P. S., Chan K., J Chromatogr. B, 812, 53—58 (2004).

10) Xu S. Y., Bian R. L., Chen X., “The Methodology of Pharmacological Experiment,” 3rd ed., People’s Medical Publishing House, Beijing, 2002, p. 916.

11) Yatin M. S., Vijay L. K., Pharmaco. Res., 50, 335—340 (2004).

12) Peters R. R., Saleh T. F., Lora M., Patry C., De Brum-Femandes A. J., Farias M. R., Ribeiro-do-Valle R. M., Life Sci., 64, 2429—2431 (1999).

13) Kim S. H., Song Y. S., Kim S. K., Kim B. C., Lim C. J., Park E. H., J. Ethnopharmacol., 93, 141—146 (2004).

14) Mujumda A. M., Misar A. V., J. Ethnopharmacol., 90, 11—15 (2004).

15) Chial H. J., Congdon R. W., Splittgerber A. G., J. Chem. Educ., 72, 76—81 (1995).

16) Atherton B. A., Cunningham E. L., Splittgerber A. G., Anal. Biochem., 233, 160—168 (1996).

17) Gurpreet K., Hinna H., Asif A., Sarwar A. M., Mohammad A., J. Ethnopharmacol., 90, 285—292 (2004).

18) Koo H. J., Song Y. S., Kim H. J., Lee Y. H., Hong S. M., Kim S. J., Kim B. C., Jin C., Lim C. J., Park E. H., Eur. J. Pharmacol., 495, 201—208 (2004).

19) Chen S., Li B. Y., Zeng Z. D., Yi L. Z., Liang Y. Z., Res. Practice Chinese Med., 18 (Suppl.), 10—12 (2004).

20) Jacobs R. S., Culver P., Langdom R., O’Brien T., White S., Tetrahedron, 41, 981—983 (1985).

1) Chiang L. C., Chang J. S., Chen C. C., Ng L. T., Lin C. C., Am. J. Chin. Med., 31, 355—362 (2003).

2) Li C., Zhao Y., An H., Lin Chuang Er Bi Yan Hou Ke Za Zhi, 15, 53—54 (2001).

3) Chang J. S., Chiang L. C., Chen C. C., Liu L. T., Wang K. C., Lin C. C., Am. J. Chin. Med., 29, 303—312 (2001).

4) Kim S. K., Ryu S. Y., No J., Choi S. U., Kim Y. S., Arch. Pharm. Res., 24, 518—521 (2001).

5) Wang D., Yu Q., Eikstadt P., Hammond D., Feng Y., Chen N., Int. Immunopharmacol., 2, 1411—1418 (2002).

6) Cho E. J., Yokozawa T., Kim S. C., Shibahara N., Park J. C., Phytomedicine, 10, 544—551 (2003).

7) Lantz C. S., Boesiger J., Song C. H., Mach N., Kobayashi T., Mulligan R. C., Nawa Y., Dranoff G., Galli S. J., Nature (London), 392, 90—93 (1998).

Gordon J. R., Burd P. R., Galli S. J., Immunol. Today, 11, 458—464 (1990).

9) Chai O. H., Kim E. K., Lee Y. H., Kim J. G., Baik B. J., Lee M. S., Han E. H., Kim H. T., Song C. H., Peptides, 22, 1421—1426 (2001).

10) Chai O. H., Lee Y. H., Han E. H., Kim H. T., Lee M. S., Song C. H., Exp. Mol. Med., 32, 179—186 (2000).

11) Roitt I., Brostoff J., Male D., “Immunology,” Chap. 21, ed. by Platts-Mills T., Mosby, New York, 2001, pp. 323—343.

12) Graevskaya E. E., Yasutake A., Aramaki R., Rubin A. B., Arch. Toxicol., 77, 17—21 (2003).

13) Hong S. H., Jeong H. J., Kim H. M., J. Ethnopharmacol., 88, 229—234 (2003).

14) Fleming T. J., Donnadieu E., Song C. H., Laethem F. V., Galli S. J., Kinet J. P., J. Exp. Med., 186, 1307—1314 (1997).

15) Cochrane D. E., Douglas W. W., Proc. Natl. Acad. Sci. U.S.A., 71, 408—412 (1974).

16) Hachisuka H., Nomura H., Sakamoto F., Mori O., Okubo K., Sasai Y., Arch. Dermatol. Res., 280, 158—162 (1988).

17) Mascotti K., McCullough J., Burger S. R., Transfusion, 40, 693—696 (2000).

18) Harvima R. J., Harvima I. T., Fraki J. E., Clin. Chim. Acta, 171, 247—256 (1988).

19) Holmeggard S. N., Acta Endocrinol. Suppl. (Copenh), 249, 1—47 (1982).

20) Lorenz D., Wiesner B., Zipper J., Winkler A., Krause E., Beyermann M., Lindau M., Bienert M., J. Gen. Physiol., 112, 577—591 (1998).

21) Alfonso A., Cabado A. G., Vieytes M. R., Botana L. M., Cell. Signal., 12, 343—350 (2000).

22) Sarkar A., Sreenivasan Y., Manna S. K., FEBS Lett., 549, 87—93 (2003).

23) Essayan D. M., J. Allergy Clin. Immunol., 108, 671—680 (2001).

Boesenbergia rotunda (Boesenbergia pandurata)

Achararit, C., Panyayong, W., and Ruchatakomut, E. 1983. Inhibitory action of some Thai herbians (medicinal plants) to fungi. Special project for the degree of B.Sc. (Pharm.), Faculty of Pharmacy, Mahidol University.

Apisaksirikul, A., and Anantasarn, V. 1984. A pharmacological study of the Thai medicinal plants. Abstract, 10th Conference of Science and Technology, Chiang Mai University, Chiang Mai.

Areekul, S., Sinchaisri, P., and Tigvatananon, S. 1987. Effect of Thai plant extracts on the oriental fruit fly I. Toxicity test. Kasetsart J. (Nat. Sci.)., 21 (4): 395-407.

Barfod, L., Kemp, K., Hansen, M., and Kharazmi, A. 2002. Chalcones from Chinese liquorice inhibit proliferation of T-cells and production of cytokines. Int. Immunopharmacol., 2(2): 545-555.

Borman, A.M., Paulous, S., and Clavel, F. 1996. Resistance of human immunodeficiency type 1 protease inhibitors: Selection of resistance mutations in the presence and absence of the drug.

J. Gen. Virol., 77: 419-426. Brinkworth, R.I., Stoermer, M.J., and Fairlie, D.P. 1992. Flavones are inhibitors of HIV-1 proteinase.
Biochem. Biophys. Res. Commu., 188 (2): 631-637.

Burke, B., and Nair, M. 1986. Phenylpropene, benzoic acid and flavonoid derivatives from fruits of Jamaican Piper species. Phytochemistry. 25(6): 1427-1430.

Itokawa, H., Morita, M., and Mihashi, S. 1981. Phenolic compounds from the rhizomes of Alpinia speciosa. Phytochemistry. 20(11): 2503-2506.

Jaipetch, T., Kanghae, S., Pancharoen, O., Patrick, V.A., Reutrakul, V., Tuntiwachwuttikul, P., and White, A.H. 1982. Constituents of Boesenbergia pandurata. Aust. J. Chem., 35: 351-361.

Jaipetch, T., Reutrakul, V., Tuntiwachwuttikul, P., and Santisuk, T. 1983. Flavonoids in the black rhizomes of Boesenbergia pandurata. Phytochemistry. 22(2): 625-626.

Kohl, N.E., Emini, E.A., and Schleif, W.A. 1988. Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. USA., 85: 4686-4690.

Lee, J.H., Kim, Y.S., Lee, C.K., Lee, H.K., and Han, S.S. 1999. Antiherpetic activity of natural naringenin alone and in combination with acyclovir and vidarabine. Yakhak Hoechi. 43(1): 77-84.

Lin, C.C., Lee, H.Y., Chang C.H., Cheng H., Namba, T., and Hattori, M. 1996. Evaluation of the liver protective principles from the root of Cudrania cochinchinensis var. gerontogea. Phytother. Res., 10(1): 13-17.

Lin, Y.M., Zhou, Y., Flavin, M.T., Zhou, L.M., Nie, W., and Chen, F.C. 2002. Chalcones and flavonoids
as anti-tuberculosis agents. Bioorganic & Med. Chem., 10(8): 2795-2802.

Ma, C.M., Nakamura, N., Miyashiro, H., and Hattori, M. 1998. Saponins and C-glycosyl flavones from the seeds of Abrus precatorius. Chem. Pharm. Bull., 46: 982-987.

Min, B.S., Ahn, B.Z., and Bae, K.H. 1996. Synthesis and structure-activity relationship of cytotoxic 5, 2′, 5′-trihydroxy-7, 8-dimethoxyflavanone analogues. Arch. Pharm. Res. 19(6): 543-550.

Min, B.S., Bae, K.H., Kim, Y.H., Miyashiro, H., Hattori, M., and Shimotono, K. 1999. Screening of Korean plants against human immunodeficiency virus type 1 protease. Phytother. Res., 13: 680-682.

Murakami, A., Kondo, A., Nakamura, Y., Ohigashi, H., and Koshimizu, K. 1993. Possible anti-tumor promoting properties of edible plants from Thailand, and identification of an active constituent, cardamonin, of Boesenbergia. Biosci. Biotech. Biochem., 57(11): 1971-1973.

Orosalan, S. 1989. Biosynthesis and proteolytic processing of retroviral proteins: an overview. Current communications in molecular biologyviral protienases as targets for chemotherapy. pp.87-100. Cold Spring Harbor laboratory press,
New York.

Pancharoen, O., Kelvin, P., Reutrakul, V., Taylor, W.C., and Tuntiwachwuttikul, P. 1987. Constituents of
the Zingiberaceae. Aust. J. Chem., 40(3): 455-459.

Pandji, C., Grimm, C., Wray, V., Witte, L., and Proksch, P. 1993. Insectcidal constituents from four species of the Zingiberaceae. Phytochemistry 34(2): 415-419.

Pathong, A., Tassaneeyakul, W., Kanjanapothi, D., Tuntiwachwuttikul, P., Reutrakul, V. 1989. Antiinflammatory
activity of 5, 7-dimethoxyflavone. Planta Med., 55(2): 133-136.

Saydam, G., Aydin, H.H., Sahin, F., Kucukoglu, O., Eriyas, E., Terzioglu, E., Buyukkececi F., and Omay, S.B. 2003. Cytotoxic and inhibitory effects of 4′, 4′-dihydroxy chalcone (RVC-588) on proliferation of leukemia HL-60 cells. Leukemia Res. 27(1): 57-64.

Tanaka, T., Ichino, K., and Ito, K. 1985. A novel flavanone, linderatone, from Lindera umbellata. Chem. Pharm. Bull. 33(6): 2602-2604.

Tewtrakul, S., Subhadhirasakul, S., and Kummee, S. 2003. HIV-1 protease inhibitory effects of medicinal plants used as self medication by AIDS patients. Songklanakarin J. Sci. Technol. 25(2): 239-243.

Thamaree, S., Pachotikarn, C., Tankeyoon, M., and Itthipanichpong, C. 1985. Effects of intestinal motility of thirty herbal medicines used in the treatment of diarrhea and dysentery. Chula. Med., 29(1): 39-51.

Trakoontiyakorn, G., Nakahara, K., Shinmoto, H., Takenaka, M., Kameyama, M., Ono, H., Yoshida, M., Nagata, T., and Tsushida, T. 2001. Structural analysis of a novel antimutagenic compound, 4-hydroxypanduratin A, and the mutagenic activity of flavonoids in a Thai spice. J. Agr. Food Chem., 49(6): 3046-3050

Tiwawech, D., M. Hirose, et al. (2000). Enhancing effects of Thai edible plants on 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline-hepatocarcinogenesis in a rat medium-term bioassay. Cancer Letters. [print] October 158(2): 195-201. {a} Research Division, National Cancer Institute, Bangkok, Thailand

Murakami, A., A. Kondo, et al. (1993). Possible anti-tumor promoting properties of edible plants from Thailand, and identification of an active constituent, cardamonin, of Boesenbergia pandurata. Bioscience Biotechnology and Biochemistry 57(11): 1971-1973. {a} Dep. Food Sci. Technology, Fac. Agric., Kyoto Univ., Kyoto 606, Japan

Pancharoen, O., K. Picker, et al. (1987). Constituents of the zingiberaceae: X. Diastereomers of (7-hydroxy-5-methoxy-2-methyl-2-(4′-methylpent-3′-enyl)-2H-chromen-8-yl)(3”-methyl-2”-(3”’-methylbut-2”’-enyl)-6”-phenylcyclohex-3”-enyl)methanone (panduratin B), a constituent of the red rhizomes of a variety of Boesenbergia pandurata. Australian Journal Of Chemistry 40(3): 455-460.

Mahidol, C., P. Tuntiwachwuttikul, et al. (1739). Constituents of Boesenbergia pandurata (Kaempferia pandurata): 3. Isolation and synthesis of racemic-boesenbergin B. Australian Journal Of Chemistry 37(8): 1739-1746.

Prebiotics and probiotics

• Prebiotics & probiotics (2nd Ed.), EMERTON V. – 01-2010 – Env. 320p. Hardback
• Prebiotics and probiotics science and technology, CHARALAMPOPOULOS Dimitris – RASTALL Robert A. – 07-2009 – Paperback
• Lactobacillus molecular biology. From genomics to probiotics., – 206p. 17×25 Hardback
• Handbook of probiotics & prebiotics (2nd Ed.), LEE Yuan Kun – 01-2009 – 600p. Hardback
• Probiotics in pediatric medicine, MICHAIL S – 10-2008 – Paperback
• Prebiotics & probiotics science & technology, CHARALAMPOPOULOS D. – RASTALL R.A. – 09-2008 – 1000p. Hardback
• Handbook of prebiotics & probiotics ingredients: health benefits & food applications, CHO S.S. – 09-2008 – 352p. 16×24 Paperback
• Therapeutic microbiology: probiotics & related strategies, VERSALOVIC J – WILSON M – 09-2008 – 404p. Hardback
• Probiotics : successful strategies from the global marketplace on PDF, 01-2007>
• Probiotics in food. Health and nutritional properties and guidelines for evaluation (Food and nutrition N° 85), – 62p. 21×30 Paperback
• Probiotics in food safety & human health, GOKTEPE I. – ABRAHAM A. – JUNEJA V.K. – 01-2006 – 512p. 15×23 Hardback
• Probiotics, Prebiotics, and Commensal Bacteria, an Issue of Gastroenterology Clinics, FRIEDMAN Gerald – 12-2005 – 240p. Hardback
• Probiotics and prebiotics : scientific aspects, TANNOCK Gerald W. – 09-2005 – 230p. Hardback
• Bacterial spore formers. Probiotics and applications, RICCA Ezio – HENRIQUES Adriano O. – 10-2004 – 244p. 21×27.6 Hardback
• Dietary fiber, prebiotics, probiotics & their role in intestinal health (IFT Basic symposium series), GORDON Dennis T. – 12-2003 – 400p. Hardback
• Probiotics and oral tolerance (probiotiques et tolerance orale) (4000430102, Dec.4, 2003) WO 03/099037A1, PRIOULT Guenolee – PECQUET Sophie – 12-2003 – Broché
• Probiotics and prebiotics : where are we going ?, TANNOCK Gérald W. – 06-2002 – 336p. 16×24 Hardback
• Probiotics 3 immunomodulation by the Gut microflora and probiotics, FULLER R. – 03-2000 – 274p. 16×24 Hardback
• Ingredients handbook : prebiotics and probiotics, 01-2000 – 224p. Paperback
• Handbook of probiotics, LEE Jay – 07-1999 – Env. 210p. 16×24 Paperback
• Probiotics: a critical review, TANNOCK Gerald W. – 01-1999 – 162p. 24×16 Hardback
• Beyond probiotics, GITTLEMAN – 12-1998 – 13.7×21.3 Soft-cover
• Probiotics, other nutritional factors and intestinal microflora, Nestlé nutrition workshop series vol.42, HANSON – 11-1998 – 288p. 22.9×15.2 Hardback
• Probiotics 2 : applications and pratical aspects, FULLER – 05-1997 – 224p. 23.4×15.6 Hardback
• Probiotics : the scientific basis, FULLER – 04-1992 – Env. 416p. 23.4×15.6 Hardback
• Probiotics (paper), TRENEV – 01-1990 – Paperback
• Probiotics, SR 57 – 05-1989 – Paperback
• Probiotics UK, EWING – 01-1989 – 124p. Hardback
• Probiotics: A Medical Dictionary, Bibliography, And Annotated Research Guide To Internet References, ICON Health Publications 176p. 28×21 Paperback
• Probiotiques et prébiotiques en alimentation humaine: Le point des connaissances actuelles, DACOSTA Yves – 05-2001 – 228p. 21×29.7 Broché
• Probiotics and oral tolerance (probiotiques et tolerance orale) (4000430102, Dec.4, 2003) WO 03/099037A1, PRIOULT Guenolee – PECQUET Sophie – 12-2003 – Broché
• Bactéries lactiques et probiotiques (Coll. STAA), LUQUET François-Marie – CORRIEU Georges – 04-2005 – 306p. 16×24
• Les probiotiques en alimentation animale humaine, LARPENT Jean-Paul – CHATEAU N. – CASTELLANOS M.I. – LARPENT J.-L. -

Antioxidants and free radicals

• Actualités pharmaceutiques n°hors serie fevrier 91: vieillissement, radicaux libres.., – Relié
• Radicaux libres et stress oxydant: Aspects biologiques et pathologiques (Retirage 2007, broché), DELATTRE Jacques – BEAUDEUX Jean-Louis – BONNEFONT-ROUSSELOT
• Introduction à la chimie des radicaux libres, PRYOR – 01-1969 – Broché
• Radicaux libres organiques (Colloques Int. CNRS), – Broché
• Radicaux libres et physiopathologie oculaire, BONNE – 01-1991 – Env. 136p. Broché
• Les radicaux libres en chimie organique, FOSSEY – 06-1993 – Env. 300p. 16×24 Broché
• Radicaux libres et stress oxydant : Aspects biologiques et pathologiques, DELATTRE Jacques – BEAUDEUX Jean-Louis – BONNEFONT-ROUSSELOT
• Free radicals in ophthalmic disorders, ZIERHUT M. – CADENAS E. – RAO N. – 03-2008 – 256p. 18×25 Hardback
• Free radicals in biology & medicine, 4th Ed., HALLIWELL Barry – GUTTERIDGE John – 09-2006 – 704p. Hardback
• Free radicals in biology & medicine, 4th Ed. (paper), HALLIWELL Barry – GUTTERIDGE John – 09-2006 – 704p. Paperback
• Free radicals in biology and medicine: from inflammation to biotechnology, BAHORUN – 01-2006 – Paperback
• Polyatomic free radicals (coll landolt-b rnstein: numerical data and functional relationships in science and technology new series 2 vol 24 d part, BROWN – 10-2005 – 526p. Hardback
• Free Radicals and Diseases: Gene Expression, Cellular Metabolism and Pathophysiology (NATO Science Series: Life & Behavioural Sciences) (v. 367), GRUNE T. – 07-2005 – 208p. Paperback
• Nitrogen & oxygen centered radicals, Landolt-Börnstein series, group 2, Molecules & radicals, Vol.26 : Magnetic properties of free radicals, Subv C, HOWARD J.A. – JAGER H. – MECKE R. – NEUGEBAUER F.A. – 03-2004 –
• Free Radicals: Enzymology, Signalling and Disease (Biochemical Society Symposia Series) (v. 71), COOPER ChrisWilson MikeDarley- – 02-2004 – 230p. Paperback
• Biomedical EPR : Part A :Free radicals, metals, medicine & physiology, (Biological magnetic resonance, Vol. 23), EATON Sandra S. – EATON Gareth R. – BERLINER Lawrence J. – 01-2004 –
• Free radicals & inhalation pathology, with CD-ROM, SCHILLER Erich – 07-2003 – 774p. Hardback
• Epr of free radicals in solids, LUND – 05-2003 – 664p. Hardback
• Free Radicals and Skin : 4th Teupitzer Colloquium, September-October 2001 (Skin Pharmacology & Applied Skin Physiology) (v. 15, No. 5), ORFANOS C.E.Tebbe B. – 09-2002 – 106p. Paperback
• Free radicals, nitric oxide & inflammation : molecular, biochemical and clinical aspects (NATO Science series, life & behavioural sciences, vol. 344), TOMASI A. – OZBEN T. – 03-2002 – 300p. 23.4×15.6 Hardback
• Free radicals in food acs symposium series 807, – 320p. 24.1×15.9 Paperback
• Free radicals and disease prevention: what you must know, LIN – 01-2001 – Soft-cover
• Nitric Oxide and Free Radicals in Peripheral Neurotransmission (Nitric Oxide in Biology & Medicine), KALSNER Stanley – 06-2000 – 360p. 23.5×15.5 Hardback
• Studies on Neurodegenerative Mechanisms in the Basal Ganglia Induced by MPTP, Excitotoxins and Hydroxyl Free Radicals in Rodents (Berichte Aus Der Pharmazie), TEISMANN Peter – 06-2000 – 332p. 20.5×14.5 Paperback
• Free Radicals in Exercise and Aging, RADAK Zsolt – 05-2000 – 240p. 22.9×15.2 Hardback
• Toxicology of the human environment : the critical role of free radicals, RHODES Chris J. – 02-2000 – 496p. 17×25 Hardback
• Free radicals. Biology & detection by spin trapping, ROSEN Gerald M. – BRITIGAN Bradley E. – HALPHERN Howard J. – POU
• Infrared vibration rotation spectroscopy from free radicals to the infrared sky, DUXUBURY – 12-1999 – Env. 488p. 25×17.3 Hardback
• The book deals with the role of both oxygen and nitrogen centred free radicals in inflammatory diseases such as rheumatoid arthritis. The well known involvement of the superoxide anion radical in the bacteridical action of inflammatory cell, WINYARD – 12-1999 – 300p. 24×17.2 Hardback
• Free radicals, antioxidants, aging and disease, KNIGHT Joseph A. – 07-1999 – 390p. 15×23 Paperback
• Free radicals in biology and medicine (3rd ed.), HALLIWELL Barry – GUTTERIDGE John M.C. – 04-1999 – Env. 936p. 17×24
• Free radicals in biology and medicine (3rd ed’ 98), HALLIWELL – 03-1999 – Hardback
• Metal ions in biological systems volume 36 : interrelations between free radicals and metal ions in life processes, SIGEL Helmut – 03-1999 – Env. 832p. 24.1×15.9 num. ill Hardback
• S centered radicals (the chemistry of free radicals), ALFASSI – 02-1999 – 500p. 15×23 Hardback
• Understanding the process of aging :the roles of mitochondria, free radicals, and antioxidants (oxidative stress and disease, 2), CADENAS Enrique – 01-1999 – 392p. 24.1×16.5 Hardback
• Numerical data & functional relationship in science & technology Groupe 2 molecules & radicals vol 25 Pt B: structure data of free polyatomic…. (book/CD), LANDOLT BORNSTE – 01-1999 – 512p. Hardback
• Molecular biology of free radicals in human diseases, ARUOMA – 01-1999 – 454p. Hardback
• Free radicals and iron : chemistry, biology and medicine, SYMONS – 08-1998 – 254p. 23×15 Hardback
• Free radicals, oxidative stress and antioxidants : pathological and physiological significance (proc. Nato Asi, Antalya, Turkey, May 24 June 4, 1997), OZBEN – 07-1998 – 406p. Hardback
• Pathophysiology of lipid peroxides and related free radicals, YAGI – 04-1998 – 182p. Hardback
• Numerical data and functional relationships in science and technology group II molecules and radicals vol 25A : structure data of free polyatomic molecules, LANDOLT BORNSTE – 02-1998 – 368p. Hardback
• Mitochondria & free radicals in neurodegenerative diseases, BEUGELSDIJK – 08-1997 – Hardback
• Oxidants, antioxidants and free radicals, BASKIN – 08-1997 – 450p. 24.1×16.5 Hardback
• Food and free radicals (Proc 1st symp Yamagata,Japan,june 16,1994), HIRAMATSU – 05-1997 – 164p. Hardback
• Free radicals in biology and environment (proc. of the NATO adv. research Workshop Bardolino, June 21/26 1996) (NATO 3, 27), MINISCI – 03-1997 – 516p. Hardback
• Free radicals in brain physiology and disorders, PACKER – 10-1996 – Hardback
• Free radicals : a practical approach (paper), PUNCHARD – 08-1996 – 334p. 23×15 Paperback
• Free radicals : a practical approach, PUNCHARD – 08-1996 – Hardback
• Chemistry in microtime : selected writings on flash photolysis, free radicals and the excited state (bound), PORTER – 08-1996 – 600p. Hardback
• Chemistry in microtime: selected writings on flash photolysis, free radicals and the excited state (paper), PORTER – 08-1996 – 600p. Paperback
• Energetics and reactivity of organic free radicals (SEARCH/4), SIMOES – 03-1996 – 256p. 21×14.8 Hardback
• Energetics and reactivity of organic free radicals (SEARCH/4), paper, SIMOES – 12-1995 – 320p. 228×152 Paperback
• Free radicals in organic chemistry, FOSSEY – 09-1995 – Hardback
• Free radicals in organic chemistry (Paper), FOSSEY – 09-1995 – 350p. 23.9×16 Hardback
• Free radicals and oxidative stress : environment, drugs & food additives (biochemical sty symposium/61), RICE EVANS – 08-1995 – 200p. 25×16 Hardback
• Free radicals in diagnostic medicine : a systems approach to laboratory technology, clinical correlations & antioxidant therapy, ARMSTRONG Donald – 06-1995 – 476p. Paperback
• Free radicals and antioxidants in food science, ARUOMA – 06-1995 – Paperback
• Antioxidants: free radicals in nutrition health and disease, GUTTERIDGE – 03-1995 – 160p. 19.7×13 Hardback
• Free radicals and oxidation phenomena in biological systems, ROBERFROID – 01-1995 – 280p. 24.1×16.5 Hardback
• Analysis of free radicals in biological systems, FAVIER – 01-1995 – 300p. 23.5×16.5 Hardback
• Radicals and the republic socialist republicanism in the irish free state 1925-1937, ENGLISH Richard – 11-1994 – Paperback
• Fifty years of free radicals, WALLING – 07-1994 – 200p. 22.9×15.2 Hardback
• Free radicals, cardiovascular dysfunction and protection strategies, KUKREJA – 03-1994 – 108p. 26×18.5 Paperback
• Trace elements and free radicals in oxidative diseases., FAVIER – 01-1994 – Paperback
• Electrochemical method & device for generating hydroxyl free radicals & oxidizing chemical substance dissolved in water (US patent 5364 508, nov 15, 1994, WERES – 01-1994 – Hardback
• Excited states and free radicals in biology and medicine, BENSASSON – 12-1993 – Env. 432p. 16X24 Paperback
• Introduction to free radicals, LEFFLER – 09-1993 – 288p. 16X24 Paperback
• Free radicals in aging, YU – 08-1993 – 368p. 23×15.2 Hardback
• Free radicals in medicine (british medical bulletin vol 49.3), SLATER – 07-1993 – 320p. Paperback
• Free radicals in tropical diseases (softcover), ARUOMA – 06-1993 – 304p. 23×15.6 Hardback
• DNA and free radicals (EH), HALLIWELL – 04-1993 – Env. 400p. 24×18 Hardback
• Oxygen Free Radicals in Tissue Damage, TARR M.Samson F. – 01-1993 – 256p. 24.8×16.5 Hardback
• Free radicals: from basic science to medicine, POLI – 01-1993 – 528p. Paperback
• Oxygen free radicals in tissue damage, TARR – 01-1993 – 296p. Hardback
• Role of free radicals in biological systems, FEHER – 01-1993 – Broché
• Oxygen free radicals and scavengers in the natural sciences, MOZSIK – 01-1993 – 356p. Broché
• Free radicals in the brain aging, neurological and mental disorders bound, PACKER – 08-1992 – 182p. 21.6×13.8 Hardback
• Free radicals and aging., CHANCE – 08-1992 – Env. 456p. Paperback
• Trace elements micronutrients and free radicals, DREOSTI – 01-1992 – 232p. 16X24 Hardback
• Free radicals and the liver (bound), CSOMOS – 01-1992 – 158p. 21.6×13.8 Soft-cover
• Free radicals, lipoproteins,and membrane lipids (NATO ASI series A, life sciences 189), CRASTESDEPAULET – 08-1990 – 408p. Paperback
• Magnetic properties of free radicals : subvolume h : organic cation radicals, Bi and polyradicals /index of substances for vols II/1, II/9 et II/17., FISCHER – 04-1990 – Hardback
• Free radicals and food additives, ARUOMA – 01-1990 – Hardback
• Free radicals in biology and medicine (2nd edition, Bound), HALLIWELL – 10-1989 – Env. 560p. 23×15 Relié(&B)
• Free radicals in the pathogenesis of liver injury: second congress, June 1988, POLI – 01-1989 – 330p. Hardback
• Free radicals in biology and medicine 2nd ed 1989, paper, HALLIWELL – 01-1989 – Env. 560p. 23X15 Paperback
• Medical, biochemical and chemical aspects of free radicals on 2 Volumes, HAYAISHI – 01-1989 – 1614p. Paperback
• Free radicals synthesis and biology, MINISCI – 01-1989 – 482p. 17X25 Relié
• Handbook of free radicals and antioxidants in biomedicine Volume 1, MIQUEL – 01-1989 – 3 volumes 18X26 Hardback
• Handbook of free radicals and antioxidants in biomedicine Volume 2, MIQUEL – 01-1989 – 3 volumes Env. 356p. 18X26 Hardback
• Handbook of free radicals and antioxidants in biomedicine Volume 3, MIQUEL – 01-1989 – 3 volumes Env. 304p. 18X26 Hardback
• Free radicals in chemistry and biology, LAZAR – 01-1989 – 304p. 19X26 Relié
• Free radicals, diseased states and antiradical interventions (Volume 6), RICE EVANS – 01-1989 – Paperback
• Free radicals in medecine selected paper from an intern. sympos. held in vienna nov.88(free radical research vol 7 numbers 3.(paper), SLATER – 01-1989 – 272p. Paperback
• Free radicals : chemistry, pathology & medicine, RICE EVANS – 01-1988 – Paperback
• Free radicals: methodology and concepts, RICE EVANS – 01-1988 – Paperback
• Organic free radicals, FISCHER – 01-1988 – Env. 252p. 17X24 Broché
• Free radicals, oxidant stress and action, RICE EVANS – 01-1987 – Paperback
• Radicals in clinical medicine, 3rd biennial meeting of the society for free radical research, West Germany, 1986, part 2 (paper), DE GROOT – 01-1987 – 330p. Paperback
• Free radicals, cell damage and disease, RICE EVANS – 01-1986 – Paperback
• Life chemistry reports vol 3 part 4 : the involvement of free radicals in pathological conditions (paper), BANNISTER – 01-1986 – 78p. Paperback
• Free radicals and arthritic diseases topics in aging research in europe vol 11. The Netherlands, june 26.28.1986, SWAAK – 01-1986 – Relié
• Free radicals: metal ions biopolymers (volume 5), BAUMONT – 01-1985 – Paperback
• Life chemistry reports vol 3 parts 1-2 : free radicals in biology and medicine (paper), BANNISTER – 01-1985 – 266p. Paperback
• Free radicals in biology vol 6 (1984), PRYOR – 01-1984 – Hardback
• Free radicals in molecular biology,aging & disease (Aging, volume 27), ARMSTRONG Donald – 01-1984 – Env. 432p. Paperback
• Antioxidants and cardiovascular disease (2nd ed ), BOURASSA Martial G. – 11-2008 – 494p. Soft-cover
• Antioxidants & ageing (Society for experimental biology series, Vol. 62), FOYER C. – THORNALLEY P. – 09-2008 – 300p. 16×24 Hardback
• Antioxidants & functional components in aquatic foods, KRISTINSSON H.G. – 01-2008 – 376p. Hardback
• Wheat antioxidants, LYU L. – YU Liangli – 12-2007 – 296p. Hardback
• Antioxidants in food and biology: Facts and fiction, FRANKEL Edwin N. – 03-2007 – 254p. Hardback
• Antioxidants & reactive oxygen species in plants, SMIRNOFF Nicholas – 07-2005 – 302p. 16×24 Hardback
• Oxidation & antioxidants in organic chemistry & biology, DENISOV E.T. – AFANAS’EV I.B. – 03-2005 – 968p. Hardback
• Oxidants & antioxidants defense systems, (Handbook of environmental chemistry, Vol. 2 : Reactions & processes, Part O), GRUNE Tilman – 03-2005 – 240p. Hardback
• Recurrent Miscarriage & Pre-eclampsia : The roles played by the immune system & antioxidants, WILSON RHODA – 09-2004 – 250p. Hardback
• Antioxidants: A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References (paperback), ICON Health Publications – 12-2003 – 384p. 28×21 Paperback
• Antioxidants and Cardiovascular Disease, NATH R.Khullar M.Singhal P.K. – 11-2003 – 326p. 24×16 Hardback
• Oxidants and Antioxidants : Ultrastructure and Molecular Biology Protocols (Methods in Molecular Biology, Vol. 196), ARMSTRONG Donald – 09-2002 – 356p. 15.5×23.5 Hardback
• Natural antioxidants in avian nutrition and reproduction, SURAI Peter F. – 01-2002 – 614p. 16×24 Hardback
• Handbook of antioxidants (2nd Ed. 2001, revised and expanded), CADENAS Enrique – PACKER Lester – 10-2001 – 712p. 18×25.5 Hardback
• Antioxidants in food : practical applications, GORDON Michael H. – POKOMY Jan – 04-2001 – 26×24.1 Hardback
• Antioxidants in food : practical applications, POKORNY – 03-2001 – 380p. 17×24 Hardback
• Oxidants and antioxidants in cutaneous biology (Current problems in dermatology, volume 29), THIELE Jens – ELSNER Peter – 02-2001 – 194p. Hardback
• Antioxidants and cardiovascular medicine, TARDIF – 09-2000 – 264p. Paperback
• The new nutrition: from antioxidants to Zucchini, BUSCH Felicia – 06-2000 – Env. 304p. Paperback
• 20. Biotic Type Antioxidants: the Prospective Search Area for Novel Chemical Drugs : Polyphenoles., PARFENOV E.A. – ZAIKOV G.E. – 05-2000 – 584p. 24.8×17.1 Paperback
• 21. Antioxidants in muscle foods, nutritional strategies to improve quality, DECKER Eric A. – FAUSTMAN Cameron – LOPEZ-BOTE Clemente J. – 03-2000 , 464p. 16×24 Hardback
• Antioxidants in diabetes management (Oxidative stress & diseases series 4), PACKER Lester – ROSER Peter – TRITSCHLER Hans J. – KING George L. –
• Handbook of antioxidants: bond dissociation energies, rate constants, activation energies & enthalpies of reactions, 2nd ed 1999, DENISOV Evguenii T. – 11-1999 – 312p. 18×25 Hardback
• Natural antioxidants and anticarcinogens in nutrition, health and disease, – 482p. 23.4×15.6 Hardback
• Free radicals, antioxidants, aging and disease, KNIGHT Joseph A. – 07-1999 – 390p. 15×23 Paperback
• Antioxidants in human health and disease, BASU – 05-1999 – 480p. Hardback
• Understanding the process of aging :the roles of mitochondria, free radicals, and antioxidants (oxidative stress and disease, 2), CADENAS Enrique – 01-1999 – 392p. 24.1×16.5 Hardback
• Antioxidants status, diet, nutrition and health, PAPAS – 01-1999 – 300p. 24.8×17.1 Hardback
• Frying of foods : oxidation, nutrient and non nutrient antioxidants, biologically active compounds and high temperatures, BOSKOU Dimitrios – ELMADFA Ibrahim – 01-1999 – 276p. 15×23 Hardback
• Every Person’s Guide to Antioxidants, SMYTHIES John – 12-1998 – 180p. Paperback
• Every Person’s Guide to Antioxidants, SMYTHIES John – 12-1998 – 180p. Paperback
• Every person’s guide to antioxidants, SMYTHIES – 12-1998 – 180p. Paperback
• Methods in enzymology vol 299 : oxidants and antioxidants part A, PACKER Lester – 10-1998 – 506p. 15×23 num. ill. Hardback
• Methods in enzymology vol 300 : oxidants and antioxidants part B, PACKER Lester – 10-1998 – 500p. 15×23 num. ill. Hardback
• Free radicals, oxidative stress and antioxidants : pathological and physiological significance (proc. Nato Asi, Antalya, Turkey, May 24 June 4, 1997), OZBEN – 07-1998 – 406p. Hardback
• Biological oxidants and antioxidants: molecular mechanisms and health effects, PACKER – 05-1998 – 372p. 24.8×16.5 Hardback
• Flavonoids in health and disease (antioxidants health diseases 7), RICE EVANS – 10-1997 – Env. 536p. 24.1×16.5 Hardback
• Naturally occurring antioxidants, LARSON – 10-1997 – 226p. 24.1×16.5 Hardback
• Lipoic acid in health and disease (antioxidants in health and disease, 6), FUCHS – 08-1997 – 496p. 23.5×15.9 Hardback
• Oxidants, antioxidants and free radicals, BASKIN – 08-1997 – 450p. 24.1×16.5 Hardback
• Antioxidants: In Science, Technology, Medicine and Nutrition (Horwood Chemical Science Series), SCOTT Gerald – 05-1997 – 350p. 25.4×18.4 Paperback
• Handbook of synthetic antioxidants (Antioxidants in health and disease 4), PACKER – 02-1997 – 472p. 24.1×16.5 Hardback
• Index of antioxidants and antiozonants, ASH Michael – 01-1997 – Env. 400p. 16.7×24 Hardback
• Antioxidants and disease prevention, GAREWAL – 01-1997 – 208p. 24.8×16.5 Hardback
• Natural antioxidants : chemistry, health effects and applications, SHAHIDI – 01-1997 – 414p. 21.6×15.9 Hardback
• Oilseed and edible oils processing, world conference II: advances in oils and fats, antioxidants and oilseed by products, KOSEOGLU – 01-1997 – 29.2×23.5 Hardback
• Advances in pharmacology vol 38 : antioxidants in disease mechanisms and therapy, AUGUST – 12-1996 – 628p. 22.9×15.2 Hardback
• Natural antioxidants and food quality in atherosclerosis and cancer prevention (Special publication 181), KUMPULAINEN – 07-1996 – 460p. 23.4×15.6 Hardback
• Handbook of antioxidants (Antioxidants in health and disease series/3), CADENAS Enrique – 02-1996 – Env. 624p. 24.1×16.5 Hardback
• Food antioxidants : technological, toxicological and health perspectives (Food science and technology series, 71), MADHAVI – 01-1996 – 718p. 24.1×16.5 Hardback
• Antioxidants and exercise, KARLSSON – 01-1996 – 224p. Hardback
• Natural antioxidants : molecular mechanisms and health effects (proc.of the intl symp. Beijing, 1995), PACKER – 01-1996 – 706p. 24.1×16.5 Hardback
• Handbook of antioxidants: bond dissociation energies, rate constants, activation energies and enthalpies of reactions, DENISOV Evguenii T. – 11-1995 – Env. 256p. 24×16.2 Hardback
• Biothols in health & disease (Antioxidants in health & diseases series/2), PACKER – 08-1995 – 552p. 24.1×16.5 Hardback
• Free radicals and antioxidants in food science, ARUOMA – 06-1995 – Paperback
• Antioxidants: free radicals in nutrition health and disease, GUTTERIDGE – 03-1995 – 160p. 19.7×13 Hardback
• The nutrition superbook 1: the antioxidants, BARILLA – 01-1995 – Soft-cover
• Maximize your health span with antioxidants:the baby boomer, BOREK – 01-1995 – Soft-cover
• Oxidants, antioxidants and disease prevention, – 24p. 21×21 Paperback
• Natural antioxidants in human health and disease, FREI – 12-1994 – 624p. 24.1×15.9 Paperback
• Oxidative processes and antioxidants, PAOLETTI – 12-1994 – Hardback
• Vitamin a in health and disease (Antioxidants in health and disease series 1), BLOMHOFF – 02-1994 – 704p. 24.1×16.5 Hardback
• Active oxygens, lipid peroxides and antioxidants, YAGI – 01-1994 – 390p. 23.5×15.6 Hardback
• Antioxidants: your complete guide, REUBEN – 01-1994 – Paperback
• Life chemistry reports vol 12 n°1: proc. of the intl. meeting on antioxidants, inflammation, cardiovascular and ophtalmic diseases (paper), BANNISTER – 01-1994 – 104p. Paperback
• The evolution of antioxidants in modern medicine, SCHMIDT – 01-1994 – 84p. Hardback
• Biological oxidants and antioxidants, PACKER – 01-1994 – Env. 276p. Hardback
• Antioxidants in higher plants, ALSCHER – 06-1993 – Hardback
• Atmospheric oxidation and antioxidants, volume 2, SCOTT – 05-1993 – 3 volumes Env. 542p. 25.4×17.8 Hardback
• Atmospheric oxidation and antioxidants, volume 3, SCOTT – 05-1993 – 3 volumes 376p. 25.4×17.8 Hardback
• Atmospheric oxidation and antioxidants in 3 Volumes set, SCOTT – 05-1993 – 1152p. 17X25 Hardback
• Atmospheric oxidation and antioxidants, vol 1, SCOTT – 01-1993 – 3 volumes Hardback
• Oxygen radicals (Proc of the 5th intl congress on oxygen radicals:active oxygen,lipid peroxides and antioxidants, Japan,17-21/11/1991)(Intl cong ser.,998), YAGI – 11-1992 – 868p. Paperback
• Phenolic compounds in food and their effects on health II : antioxidants & cancer prevention (ACS symposium series 507, CHI TANG HO – 09-1992 – 2 volumes 402p. 22.8×15.2 Hardback
• Lipid-soluble antioxidants : biochemistry and clinical applications, ONG – 08-1992 – 640p. 17X24 Hardback
• Biological free radical oxidations and antioxidants, URSINI – 01-1992 – Paperback
• Oxidative stress oxidants and antioxidants, SIES – 01-1991 – Hardback
• Antioxidants in therapy and preventive medicine (advances in experimental medicine and biology, vol. 264), EMERIT – 06-1990 – 574p. Hardback
• Food antioxidants, HUDSON – 05-1990 – Env. 318p. 14X22 Hardback
• Oxygen radicals in biological systems Pt B : oxygen radicals and antioxidants (methods in enzymology/186), METHODS 186 – 01-1990 – 856p. 22.9×15.2 Hardback
• Handbook of free radicals and antioxidants in biomedicine Volume 1, MIQUEL – 01-1989 – 3 volumes 18X26 Hardback
• Handbook of free radicals and antioxidants in biomedicine Volume 2, MIQUEL – 01-1989 – 3 volumes Env. 356p. 18X26 Hardback
• Handbook of free radicals and antioxidants in biomedicine Volume 3, MIQUEL – 01-1989 – 3 volumes Env. 304p. 18X26 Hardback
• Organosulfur antioxidants in hydrocarbon oils,vol 4 part 6 (paper), HARP – 01-1985 – 36p. Broché
• Specifications for identity and purity of thickening agents,anticaking , antimicrobials, antioxidants and emulsifiers (Alimentation &
• Toxicological Evaluation of Some Food Ad ditives Including Anticaking , Ant imicrobials, Antioxidants,
• Review of the Technological Efficacy of Some Antioxidants and Synergists (A), – 144p. Paperback
• Evaluation of the Toxicity of a Number o f Antimicrobials and Antioxidants, – 104p. Paperback
• Antioxidants and cardiovascular disease, second edition (2nd ed ), BOURASSA Martial G. 494p. Hardback
• Antioxidants and cardiovascular disease, second edition (2nd ed ), BOURASSA Martial G. Paperback
• Handbook of oxidants and antioxidants in exercise, SEN 1120p. 24.8×17.1 Hardback
• Lipid-soluble Antioxidants: Biochemistry and Clinical Applications , and Cell Biology Updates)
• Antioxidants, proceedings of conference Paperback
• Antioxidants : train longer, train harder Paperback
• Note for guidance inclusion of antioxidants and antimicrobial preservatives in medicinal products (QWP) ref 115/95 Hardback